ImmunoGen, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2015 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
ImmunoGen, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2015 to 2022.
  • ImmunoGen, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $39K, a 93.7% decline year-over-year.
  • ImmunoGen, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $27.6M, a 92.3% decline from 2021.
  • ImmunoGen, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $356M, a 81.7% increase from 2020.
  • ImmunoGen, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $196M, a 6713% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $27.6M -$328M -92.3% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-01
2021 $356M +$160M +81.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-01
2020 $196M +$193M +6713% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $2.87M -$164M -98.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $167M +$66.2M +65.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $101M -$1.16M -1.14% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-11
2016 $102M -$96.8M -48.7% Jul 1, 2015 Jun 30, 2016 10-K 2019-03-01
2015 $199M Jul 1, 2014 Jun 30, 2015 10-K 2018-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.